Compare CRIS & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRIS | BRLT |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 36.6M |
| IPO Year | 2000 | 2021 |
| Metric | CRIS | BRLT |
|---|---|---|
| Price | $1.09 | $1.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $16.50 | $1.80 |
| AVG Volume (30 Days) | ★ 111.0K | 59.3K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,650,000.00 | ★ $432,597,000.00 |
| Revenue This Year | $6.13 | $5.92 |
| Revenue Next Year | $8.44 | $4.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.56 | 1.31 |
| 52 Week Low | $1.02 | $1.25 |
| 52 Week High | $4.50 | $3.10 |
| Indicator | CRIS | BRLT |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 42.94 |
| Support Level | $1.14 | $1.71 |
| Resistance Level | $1.41 | $2.02 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 0.03 | 25.86 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.